Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells-Reference-Cited by-同舟云学术

Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells

Published:2016-09-15 Issue:9 Volume:21 Page:1236
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Zhang Xiao-Yu,Zhang Yun-Kai,Wang Yi-Jun,Gupta Pranav,Zeng Leli,Xu Megan,Wang Xiu-Qi,Yang Dong-Hua,Chen Zhe-Sheng

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/21/9/1236/pdf

Reference42 articles.

1. Multidrug resistance in cancer: role of ATP–dependent transporters

2. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

3. Multidrug Resistance: Can New Drugs Help Chemotherapy Score Against Cancer?

4. Multidrug resistance in ovarian cancer

5. Multidrug Resistance Proteins (MRPs) and Cancer Therapy

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation through naphtho[2,3‐a]pyrene on mutated EGFR mediated autophagy in NSCLC: Cellular model system unleashing therapeutic potential;IUBMB Life;2024-09-14

2. Enhancement of Chemotherapy Efficacy in Cervical Cancer via MAPK Pathway Inhibition by Osimertinib;Cancer Investigation;2024-05-27

3. A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol;2024-04-16

4. Exploring the Impact of Novel Anti-Cancer Therapies on Jaw Osteonecrosis and Other Bones: A Comprehensive Review;Journal of Clinical Medicine;2024-03-25

5. Design and Self Assembly of Tri-Terpene Peptide Conjugates and Their Interactions with EGFR and EGFR Mutant Receptors: An In Silico and In Vitro Study;International Journal of Peptide Research and Therapeutics;2023-12-14